Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$70.86 - $89.93 $176,583 - $224,105
2,492 New
2,492 $184,000
Q3 2023

Nov 09, 2023

BUY
$53.47 - $96.07 $549,029 - $986,446
10,268 New
10,268 $562,000
Q2 2022

Aug 11, 2022

SELL
$20.56 - $32.15 $44,347 - $69,347
-2,157 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$12.58 - $26.94 $18,794 - $40,248
-1,494 Reduced 40.92%
2,157 $58,000
Q4 2021

Feb 11, 2022

SELL
$19.16 - $32.68 $9,503 - $16,209
-496 Reduced 11.96%
3,651 $70,000
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $14,826 - $19,739
572 Added 16.0%
4,147 $137,000
Q2 2021

Aug 10, 2021

SELL
$21.63 - $40.07 $88,423 - $163,806
-4,088 Reduced 53.35%
3,575 $119,000
Q1 2021

May 12, 2021

BUY
$17.75 - $47.82 $136,018 - $366,444
7,663 New
7,663 $318,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.31B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.